Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration

Purpose To investigate the plasma levels of amyloid beta (Aβ) and select inflammatory mediators in patients with various stages of AMD compared to that of age-matched controls, and discern a relationship to disease severity.